Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Immunogenicity and Safety of a Purified Vero Rabies Vaccine
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
May 09, 2017
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Sponsor GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
October 11, 2023
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Sponsor GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Vaccine Prevention of Rabies Adopts 4-shot Immunization Method
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
September 22, 2022
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
September 21, 2022
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Prevention of Rabies With Four Doses of Rabies Vaccine
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
September 19, 2022
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
April 21, 2021
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Institut Pasteur du Cambodge | Institut Pasteur de Madagascar
Deal Size : Inapplicable
Deal Type : Inapplicable
Immunity Persistence After Abridged Intradermal Rabies PEP
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
April 02, 2021
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Institut Pasteur du Cambodge | Institut Pasteur de Madagascar
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Immunogenicity and Safety of A Lyophilized Purified Human Diploid Cell Rabies Vaccine .
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
June 03, 2019
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Beijing Minhai Biotechnology
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Immunogenicity of Freeze-dried Rabies Vaccine(MRC-5 Cell) in Chinese Humans
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
November 11, 2014
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Beijing Minhai Biotechnology
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Beijing Minhai Biotechnology
Deal Size : Inapplicable
Deal Type : Inapplicable
The Safety Research of Freeze-dried Rabies Vaccine(MRC-5 Cell) in Chinese Humans
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
November 02, 2014
Lead Product(s) : Rabies Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Beijing Minhai Biotechnology
Deal Size : Inapplicable
Deal Type : Inapplicable